Research increasingly links high UPF consumption with obesity, type 2 diabetes, cardiovascular disease, and premature mortality. Evidence suggests that UPFs can encourage overeating because they are highly palatable, energy-dense and often designed for frequent consumption. Studies also indicate that additives and processing methods may affect gut microbiota, inflammation and metabolic health. In addition to metabolic effects, consumption of such obesogenic diets is associated with mild cognitive impairment. Gut microorganisms communicate with the brain via microbial metabolites, immune signalling, endocrine pathways, and the vagus nerve. In rats, higher cafeteria (processed) diet exposure produced greater spatial memory impairments and larger shifts in gut microbiota species richness and beta diversity (Kendig et al, 2023). Human studies have also reported associations between greater microbial diversity and better cognitive performance, suggesting that diet-induced changes in the gut microbiome may influence neuroinflammatory and metabolic pathways implicated in cognitive decline and brain ageing.
While debate continues about the precise mechanisms involved, the overall evidence suggests that excessive reliance on UPF contributes significantly to the rising global burden of chronic disease. This presentation will highlight some of the nuances of the current UPF debate, eg. balancing the benefits of processing, and issues with the simplified NOVA 1-4 classification.